Position
Squarepoint Ops LLC in Janux Therapeutics, Inc.
Back to the book · All holders of JANX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $39.1K$13.80 → $13.90
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 391K | $5.4M | — | — | — | 0.0% |
| Q1 2026 | 604K | $8.4M | $13.90 | $39.1K | $2.96M | 0.0% |